3 ms·
From the article you linked: > Moreover, we suggest that orphan drugs have greater > profitability when considered in the full context of > develop
by peteretep 11y ago
From the article you linked:
> Moreover, we suggest that orphan drugs have greater
> profitability when considered in the full context of
> developmental drivers including government financial
> incentives, smaller clinical trial sizes, shorter
> clinical trial times and higher rates of regulatory
> success
- mikeyouse 11y agoThe original statement was that we don't develop treatments for diseases unless they affect rich people, the existence of orphan drug markets and regulations is evidence that we do develop these treatments.